Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience

被引：4

作者：

Suleman, Adam ^{[1
]}

Liu, Jiajia ^{[1
]}

Hicks, Lisa K. ^{[1
,2
]}

Drori, Adi Klil ^{[3
]}

Crump, Michael ^{[1
,4
]}

Kridel, Robert ^{[1
,4
]}

Prica, Anca ^{[1
,4
]}

Berinstein, Neil ^{[1
,5
]}

机构：

[1] Univ Toronto, Fac Med, Toronto, ON, Canada

[2] St Michaels Hosp, Div Med Oncol & Hematol, Toronto, ON, Canada

[3] AbbVie Inc, N Chicago, IL USA

[4] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada

来源：

HAEMATOLOGICA | 2023年 / 108卷 / 04期

关键词：

D O I：

10.3324/haematol.2022.282014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1186 / 1189

页数：4

共 50 条

[1] Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma
Beca, Jaclyn M.
Raza, Kaiwan
Mow, Elena
Keech, James
Kouroukis, C. Tom
LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1097 - 1107
[2] Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma
Yi, Jun Ho
Kim, Seok Jin
Yang, Deok-Hwan
Do, Young Rok
Won, Jong Ho
Baek, Dongwon
Shin, Ho Jin
Kim, Dae Sik
Kim, Hyo Jung
Kang, Ka-won
Bae, Sung Hwa
Kwon, Ji-Hyun
Kwon, Jung Hye
Park, Byeong Bae
Kim, Won Seog
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1773 - 1781
[3] Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
Zhao, Defeng
Qian, Liren
Shen, Jianliang
Liu, Xiaopeng
Mei, Ke
Cen, Jian
Wang, Yaming
Li, Congyong
Ma, Yuanyuan
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (06) : 1081 - 1086
[4] Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
Sun, Xuefei
Liu, Jing
Wang, Yaming
Bai, Xueyan
Chen, Yuedan
Qian, Jun
Zhu, Hong
Liu, Fusheng
Qiu, Xiaoguang
Sun, Shengjun
Ji, Nan
Liu, Yuanbo
ONCOTARGET, 2017, 8 (30) : 49156 - 49164
[5] Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases
Liu, Jing
Sun, Xue-Fei
Qian, Jun
Bai, Xue-Yan
Zhu, Hong
Cui, Qu
Li, Xiao-Yan
Chen, Yue-Dan
Wang, Ya-Ming
Liu, Yuan-Bo
MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 949 - 953
[6] Methotrexate-Cytarabine-Dexamethasone Combination Chemotherapy with or without Rituximab in Patients with Primary Central Nervous System Lymphoma
Liu, Jing
Sun, Xuefei
Bai, Xueyan
Chen, Yuedan
Qian, Jun
Zhu, Hong
Wang, Yaming
Ji, Nan
Sun, Shengjun
Wang, Yajie
Liu, Yuanbo
BLOOD, 2016, 128 (22)
[7] Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma
Shen, Haorui
Wu, Jia-Zhu
Liang, Jin-Hua
Yin, Hua
Wang, Li
Li, Jianyong
Xu, Wei
BLOOD, 2022, 140 : 3821 - 3822
[8] Thiotepa, Orelabrutinib, and Methotrexate Combined with or without the Rituximab Regimens in the Treatment of Patients with Central Nervous System Lymphoma
Zeng, Ruolan
Sun, Zhongyi
Xiao, Ling
Hui, Zhou
BLOOD, 2022, 140 : 9536 - 9537
[9] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
Kansara, Roopesh
Shenkier, Tamara N.
Connors, Joseph M.
Sehn, Laurie H.
Savage, Kerry J.
Gerrie, Alina S.
Villa, Diego
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
[10] Outcome of patients with newly diagnosed primary central nervous system lymphoma after sequential high-dose methotrexate, cytarabine, thiotepa based chemoimmunotherapy followed by autologous stem cell transplantation
Cernauskiene, S.
Ringeleviciute, U.
Zucenka, A.
Peceliunas, V.
Griskevicius, L.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 300 - 300

← 1 2 3 4 5 →